West Pharmaceutical Services (WST) Enterprise Value (2016 - 2025)
Historic Enterprise Value for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to -$791.3 million.
- West Pharmaceutical Services' Enterprise Value fell 6328.93% to -$791.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$791.3 million, marking a year-over-year decrease of 6328.93%. This contributed to the annual value of -$791.3 million for FY2025, which is 6328.93% down from last year.
- As of Q4 2025, West Pharmaceutical Services' Enterprise Value stood at -$791.3 million, which was down 6328.93% from -$628.5 million recorded in Q3 2025.
- In the past 5 years, West Pharmaceutical Services' Enterprise Value ranged from a high of -$404.2 million in Q1 2025 and a low of -$898.6 million during Q3 2023
- Over the past 5 years, West Pharmaceutical Services' median Enterprise Value value was -$677.8 million (recorded in 2021), while the average stood at -$665.6 million.
- In the last 5 years, West Pharmaceutical Services' Enterprise Value surged by 4537.06% in 2024 and then crashed by 6328.93% in 2025.
- Over the past 5 years, West Pharmaceutical Services' Enterprise Value (Quarter) stood at -$762.6 million in 2021, then fell by 17.27% to -$894.3 million in 2022, then grew by 4.52% to -$853.9 million in 2023, then soared by 43.25% to -$484.6 million in 2024, then plummeted by 63.29% to -$791.3 million in 2025.
- Its Enterprise Value was -$791.3 million in Q4 2025, compared to -$628.5 million in Q3 2025 and -$509.7 million in Q2 2025.